| Cloning and functional expression of a human heparanase gene PH Kussie, JD Hulmes, DL Ludwig, S Patel, EC Navarro, AP Seddon, ... Biochemical and biophysical research communications 261 (1), 183-187, 1999 | 258 | 1999 |
| High heparanase activity in multiple myeloma is associated with elevated microvessel density T Kelly, HQ Miao, Y Yang, E Navarro, P Kussie, Y Huang, V MacLeod, ... Cancer research 63 (24), 8749-8756, 2003 | 215 | 2003 |
| Anti-vascular endothelial growth factor receptor-1 antagonist antibody as a therapeutic agent for cancer Y Wu, Z Zhong, J Huber, R Bassi, B Finnerty, E Corcoran, H Li, E Navarro, ... Clinical cancer research 12 (21), 6573-6584, 2006 | 188 | 2006 |
| Development of heparanase inhibitors for anti-cancer therapy HQ Miao, H Liu, E Navarro, P Kussie, Z Zhu Current medicinal chemistry 13 (18), 2101-2111, 2006 | 125 | 2006 |
| Potent neutralization of VEGF biological activities with a fully human antibody Fab fragment directed against VEGF receptor 2 HQ Miao, K Hu, X Jimenez, E Navarro, H Zhang, D Lu, DL Ludwig, ... Biochemical and biophysical research communications 345 (1), 438-445, 2006 | 118 | 2006 |
| 1-[4-(1H-Benzoimidazol-2-yl)-phenyl]-3-[4-(1H-benzoimidazol-2-yl)-phenyl]-urea derivatives as small molecule heparanase inhibitors W Pan, HQ Miao, YJ Xu, EC Navarro, JR Tonra, E Corcoran, A Lahiji, ... Bioorganic & medicinal chemistry letters 16 (2), 409-412, 2006 | 83 | 2006 |
| The structural basis for the function of two anti-VEGF receptor 2 antibodies MC Franklin, EC Navarro, Y Wang, S Patel, P Singh, Y Zhang, K Persaud, ... Structure 19 (8), 1097-1107, 2011 | 54 | 2011 |
| Cloning, expression, and purification of mouse heparanase HQ Miao, E Navarro, S Patel, D Sargent, H Koo, H Wan, A Plata, Q Zhou, ... Protein Expression and Purification 26 (3), 425-431, 2002 | 54 | 2002 |
| N-(4-{[4-(1H-Benzoimidazol-2-yl)-arylamino]-methyl}-phenyl)-benzamide derivatives as small molecule heparanase inhibitors YJ Xu, HQ Miao, W Pan, EC Navarro, JR Tonra, S Mitelman, MM Camara, ... Bioorganic & medicinal chemistry letters 16 (2), 404-408, 2006 | 50 | 2006 |
| LY3076226, a novel anti-FGFR3 antibody drug conjugate exhibits potent and durable anti-tumor activity in tumor models harboring FGFR3 mutations or fusions D Surguladze, A Pennello, X Ren, T Mack, A Rigby, P Balderes, ... Cancer Research 79 (13_Supplement), 4835-4835, 2019 | 13 | 2019 |
| High heparanase activity in multiple myeloma is associated with elevated microvessel density T Kelly, HQ Miao, Y Yang, E Navarro, P Kussie, Y Huang, V MacLeod, ... JOURNAL OF BONE AND MINERAL RESEARCH 19 (9), 1580-1580, 2004 | | 2004 |
| Heparanase Expression in Murine Corneas Infected with Pseudonomas Aeruginosa RS Berk, Z Dong, M Katar, I Vlodavsky, HQ Miao, P Kussie, E Navarro, ... Investigative Ophthalmology & Visual Science 43 (13), 35-35, 2002 | | 2002 |
| Anti-Vascular Endothelial Growth Factor Receptor-1Antagonist Antibody as aTherapeutic Agent for Cancer E Navarro, P Balderes, X Jimenez, H Koo, VRM Mangalampalli, ... | | |
